OBSN — Obseva SA Share News
0.000.00%
Last trade - 00:00- CH₣0.14m
- -CH₣2.20m
- $19.64m
Swiss stocks - Factors to watch on February 11
Brief: Obseva Enters Into Licensing Agreement With Theramex
Brief: Obseva Provides Update On EU Marketing Authorisation Process For Linzagolix, An Oral Gnrh Antagonist, For The Treatment Of Uterine Fibroids
Brief: Obseva Provides Update On EU Marketing Authorisation Process For Linzagolix, An Oral GNRH Antagonist, For The Treatment Of Uterine Fibroids
U.S. STOCKS ON THE MOVE-Silvergate, United Parcel Service, Li Auto
ObsEva gains on positive late-stage trial results of endometriosis treatment
Brief: Obseva Announces Topline Results For Linzagolix
Swiss stocks - Factors to watch on January 6
Brief: ObsEva SA Has Been Selected For Addition To Nasdaq Biotechnology Index
Brief: Obseva Announces Appointment Of Will Brown As CFO
Obseva jumps after FDA accepts menstrual bleeding drug for review
Brief: Obseva Announces U.S. FDA Acceptance Of New Drug Application For Linzagolix
Swiss stocks - Factors to watch on November 11
Brief: Obseva SA Files Prospectus Related To Resale Of Up To 11.5 Mln Of Common Shares Of Obseva SA By Selling Shareholders
Swiss stocks - Factors to watch on November 1
Brief: Obseva Announces Management Change
Swiss stocks - Factors to watch on Oct 19
Brief: Obseva Announces Appointment Of Luigi Marro As Chief Transformation Officer
Swiss stocks - Factors to watch on September 15